Exploiting shape, cellular-hitchhiking and antibodies to target nanoparticles to lung endothelium: Synergy between physical, chemical and biological approaches

被引:88
作者
Anselmo, Aaron C. [1 ]
Kumar, Sunny [1 ]
Gupta, Vivek [2 ]
Pearce, Austin M. [1 ]
Ragusa, Analisa [1 ]
Muzykantov, Vladimir [3 ,4 ]
Mitragotri, Samir [1 ]
机构
[1] Univ Calif Santa Barbara, Dept Chem Engn, Ctr Bioengn, Santa Barbara, CA 93106 USA
[2] Keck Grad Inst, Sch Pharm, Claremont, CA 91711 USA
[3] Univ Penn, Perelman Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA
[4] Univ Penn, Perelman Sch Med, Ctr Translat Targeted Therapeut & Nanomed, Philadelphia, PA 19104 USA
基金
美国国家科学基金会;
关键词
Cellular hitchhiking; Cell-mediated drug delivery; Erythrocytes; Red blood cells; Shape; Nanoparticles; RED-BLOOD-CELLS; DRUG-DELIVERY CARRIERS; IN-VIVO; POLYMERIC NANOPARTICLES; MEDIATED DELIVERY; CANCER-THERAPY; CIRCULATION; CLEARANCE; ADSORPTION; SURFACE;
D O I
10.1016/j.biomaterials.2015.07.043
中图分类号
R318 [生物医学工程];
学科分类号
100103 [病原生物学];
摘要
Delivery of nanoparticles to target specific tissues remains a challenge due to their rapid removal from circulation by the reticuloendothelial (RES) system. The majority of past research has addressed this issue via chemical modification of nanoparticles in the form of hydrophilic coatings which reduces adsorption of opsonins that trigger RES clearance. Recently, additional approaches have been developed which leverage the natural mechanisms our own circulatory cells use to avoid immune system clearance. One such method, called 'cellular-hitchhiking', accomplishes this by non-covalent attachment of nanoparticles to the surface of red blood cells. Concomitantly, approaches that make use of modified nanoparticle geometry, that is rod-shaped nanoparticles, have also been used to avoid immune system clearance and improve tissue targeting. Here, we systematically investigate three approaches and their combinations to improve lung targeting while avoiding RES clearance. Our results show that an approach that combines targeting antibodies (anti-ICAM-1), rod-shaped particles and cellular hitchhiking into one delivery system effectively lowered the accumulated concentration of nanoparticles in RES organs by over two-fold as compared to any other combination or single method, while simultaneously increasing the concentration of accumulated nanoparticles in the lungs from 1.2 to 8.9 fold. The strategy described here offers a novel means that combine chemical, physical and biological approaches to maximize tissue targeting. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 58 条
[1]
The accelerated blood clearance (ABC) phenomenon: Clinical challenge and approaches to manage [J].
Abu Lila, Amr S. ;
Kiwada, Hiroshi ;
Ishida, Tatsuhiro .
JOURNAL OF CONTROLLED RELEASE, 2013, 172 (01) :38-47
[2]
Albanese A, 2012, ANNU REV BIOMED ENG, V14, P1, DOI [10.1146/annurev.bioeng-071811-150124, 10.1146/annurev-bioeng-071811-150124]
[3]
A Review of Clinical Translation of Inorganic Nanoparticles [J].
Anselmo, Aaron C. ;
Mitragotri, Samir .
AAPS JOURNAL, 2015, 17 (05) :1041-1054
[4]
Elasticity of Nanopartides Influences Their Blood Circulation, Phagocytosis, Endocytosis, and Targeting [J].
Anselmo, Aaron C. ;
Zhang, Mengwen ;
Kumar, Sunny ;
Vogus, Douglas R. ;
Menegatti, Stefano ;
Helgeson, Matthew E. ;
Mitragotri, Samir .
ACS NANO, 2015, 9 (03) :3169-3177
[5]
Monocyte-mediated delivery of polymeric backpacks to inflamed tissues: a generalized strategy to deliver drugs to treat inflammation [J].
Anselmo, Aaron C. ;
Gilbert, Jonathan B. ;
Kumar, Sunny ;
Gupta, Vivek ;
Cohen, Robert E. ;
Rubner, Michael F. ;
Mitragotri, Samir .
JOURNAL OF CONTROLLED RELEASE, 2015, 199 :29-36
[6]
Platelet-like Nanoparticles: Mimicking Shape, Flexibility, and Surface Biology of Platelets To Target Vascular Injuries [J].
Anselmo, Aaron C. ;
Modery-Pawlowski, Christa Lynn ;
Menegatti, Stefano ;
Kumar, Sunny ;
Vogus, Douglas R. ;
Tian, Lewis L. ;
Chen, Ming ;
Squires, Todd M. ;
Sen Gupta, Anirban ;
Mitragotri, Samir .
ACS NANO, 2014, 8 (11) :11243-11253
[7]
Cell-mediated delivery of nanoparticles: Taking advantage of circulatory cells to target nanoparticles [J].
Anselmo, Aaron C. ;
Mitragotri, Samir .
JOURNAL OF CONTROLLED RELEASE, 2014, 190 :531-541
[8]
An overview of clinical and commercial impact of drug delivery systems [J].
Anselmo, Aaron C. ;
Mitragotri, Samir .
JOURNAL OF CONTROLLED RELEASE, 2014, 190 :15-28
[9]
Delivering Nanoparticles to Lungs while Avoiding Liver and Spleen through Adsorption on Red Blood Cells [J].
Anselmo, Aaron C. ;
Gupta, Vivek ;
Zern, Blaine J. ;
Pan, Daniel ;
Zakrewsky, Michael ;
Muzykantov, Vladimir ;
Mitragotri, Samir .
ACS NANO, 2013, 7 (12) :11129-11137
[10]
Expression of lung vascular and airway ICAM-1 after exposure to bacterial lipopolysaccharide [J].
BeckSchimmer, B ;
Schimmer, RC ;
Warner, RL ;
Schmal, H ;
Nordblom, G ;
Flory, CM ;
Lesch, ME ;
Friedl, HP ;
Schrier, DJ ;
Ward, PA .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1997, 17 (03) :344-352